Neurontin - API Insight, 2018 - ResearchAndMarkets.com

November 30, 2018

DUBLIN--(BUSINESS WIRE)--Nov 30, 2018--The “Neurontin - API Insight,2018” drug pipelines has been added to ResearchAndMarkets.com’s offering.

This report provides product and API manufacturers’ details across the globe along with the location. The report gives the clear idea on the country wise DMF filed by worldwide companies related to Neurontin . The report also highlights the patent details of Neurontin.


A comprehensive product overview including product description, regulatory milestones, safety, pharmacological properties, clinical trials, and product development activities have been elaborated in this report Patent information around Neurontin in United States (US) and Europe (EU) has been highlighted API manufacturers for Neurontin in United States, Europe, China and India The report contains historical and forecasted sales for Neurontin till 2020 Enlists the market competition and emerging therapies in the space where Neurontin operates

Reasons to Purchase

Evaluate the marketing status of Neurontin to exploit opportunities for generic Neurontin development opportunities Design effective counter-strategies to gain competitive advantage by identifying the key patent expiry details with respect to Neurontin API intelligence over Neurontin and gaining primary intelligence over Active Ingredient manufacturers by country Make more informed business decisions from insightful and in-depth analysis of the Neurontin ’s performance

Key Topics Covered

1. Neurontin Overview

2. Neurontin Global Sales Assessment

Neurontin Historical Global Sales Neurontin Forecasted Global Sales

3. Product Description

Mechanism of Action Pharmacodynamic Properties Pharmacokinetic Properties

4. Product Details by country

5. Patent Information

6. Global API Manufacturers Assessment

Active Pharmaceutical Ingredient (API) Manufacturers by Country Active Pharmaceutical Ingredient (API) Manufacturers by Region

List of Tables

Table 1: Neurontin Historical Global Sales till 2017 (in million USD)

Table 2: Neurontin Forecasted Global Sales from 2018-2020 (in million USD)

Table 3: Neurontin General Description

Table 4: Product Details by country

Table 5: Patent Information

Table 6: API Manufacturers by country

Table 7: API Manufacturers by Region

List of Figures

Figure 1: Neurontin Historical Global Sales till 2017 (in million USD)

Figure 2: Neurontin Forecasted Global Sales from 2018-2020 (in million USD)

Figure 3: Neurontin Patent Details

Figure 4: API Manufacturers by Country

Figure 5: API Manufacturers by Region

For more information about this drug pipelines report visit https://www.researchandmarkets.com/research/4nfkcj/neurontin_api?w=4

View source version on businesswire.com:https://www.businesswire.com/news/home/20181130005442/en/

CONTACT: ResearchAndMarkets.com

Laura Wood, Senior Press Manager


For E.S.T Office Hours Call 1-917-300-0470

For U.S./CAN Toll Free Call 1-800-526-8630

For GMT Office Hours Call +353-1-416-8900

Related Topics:Central Nervous System Drugs



SOURCE: Research and Markets

Copyright Business Wire 2018.

PUB: 11/30/2018 01:29 PM/DISC: 11/30/2018 01:29 PM


Update hourly